Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06556030
PHASE4

A Multicentre, Randomised, Single-blind, Controlled Protocol to Evaluate the Efficacy of Early Administration of Botulinum Toxin for Primary Midline Closure in Patients With Open Abdomen.

Sponsor: Instituto de Investigación Hospital Universitario La Paz

View on ClinicalTrials.gov

Summary

A multicentre, randomised, single-blind, controlled protocol to evaluate the efficacy of early administration of botulinum toxin for primary midline closure in patients with open abdomen. Early use (less than 48 hours) of botulinum toxin as a neuromuscular abdominal wall blocker in patients whose abdomen is left open, regardless of the cause, will improve postoperative outcome and prognosis, leading to significantly higher percentages of primary midline closure.

Official title: Botulinum Toxin in Open Abdomen Closure

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2025-01

Completion Date

2026-12

Last Updated

2024-08-15

Healthy Volunteers

No

Interventions

DRUG

Botulinum Toxin A

Botulinum Toxin

OTHER

CONTROL

Saline Solution